| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/29/2003 | WO2002036117A1 Medicinal compositions for concominant use as anticancer atent |
| 04/29/2003 | US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery |
| 04/29/2003 | US6555676 Antitumor agents |
| 04/29/2003 | US6555667 Hypoxia-regulated genes |
| 04/29/2003 | US6555651 Ligand binding site of rage and uses thereof |
| 04/29/2003 | US6555575 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 04/29/2003 | US6555571 3-methyl -chromane or thiochromane derivatives |
| 04/29/2003 | US6555558 Oral dosage self-emulsifying formulations of pyranone protease inhibitors |
| 04/29/2003 | US6555542 Sulfonamide lactam inhibitors of FXa and method |
| 04/29/2003 | US6555539 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis |
| 04/29/2003 | US6555535 Tricyclic biphenyl sulfonamide matrix metalloproteinase inhibitors |
| 04/29/2003 | US6555533 Specific antitumor activity against breast, colon, lung, prostate cancers and melanomas |
| 04/29/2003 | US6555527 Hematopoietic, myeloprotecting, antitumor immune cells generating and radiosensitizing polysaccharide isolated from Panax ginseng |
| 04/29/2003 | US6555520 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and immunologicval disorders |
| 04/29/2003 | US6555518 2',2'-difluoronucleosides for suppressing rejection of transplants in mammals; for treatment of autoimmune diseases |
| 04/29/2003 | US6555377 Process for production of mammalian cell lines |
| 04/29/2003 | US6555368 Single-chain antibody introduced into the minor capsid proteins so that the adenoviral vector can be targeted to a particular cell type |
| 04/29/2003 | US6555352 Peptide for use in human therapeutics and diagnostic compositions |
| 04/29/2003 | US6555322 Connective tissue growth factor (CTGF); drug screening for agents that modulate the activity of a CTGF receptor comprising the alpha 2- macroglobulin receptor |
| 04/29/2003 | CA2227513C New ellipticine derivatives, their preparation process and the pharmaceutical compositions containing them |
| 04/29/2003 | CA2159098C Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 04/29/2003 | CA2011992C Use of human interferon-beta for stimulation of erythropoiesis |
| 04/25/2003 | CA2409910A1 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| 04/24/2003 | WO2003034069A2 Tcmp 03 protein for use in cancer therapy |
| 04/24/2003 | WO2003034067A1 Modulation of tor |
| 04/24/2003 | WO2003034028A2 Methods for identifying and using modulators of estrogen related receptor gamma |
| 04/24/2003 | WO2003033720A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 04/24/2003 | WO2003033700A1 Method for inhibiting the replication of viruses |
| 04/24/2003 | WO2003033696A1 Vegf antisense compound |
| 04/24/2003 | WO2003033692A2 Use of the adenoviral e2 late promoter |
| 04/24/2003 | WO2003033680A2 Kinases and phosphatases |
| 04/24/2003 | WO2003033674A2 Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 04/24/2003 | WO2003033660A2 9136, a human aldehyde dehydrogenase family member and uses therefor |
| 04/24/2003 | WO2003033654A2 Direct targeting binding proteins |
| 04/24/2003 | WO2003033653A2 Affinity enhancement agents |
| 04/24/2003 | WO2003033529A2 Tr4, tr4 activators, tr4 inhibitors or tr4-associated molecules for treating leukaemic diseases |
| 04/24/2003 | WO2003033525A1 Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament |
| 04/24/2003 | WO2003033523A2 Cytotoxic compounds |
| 04/24/2003 | WO2003033518A1 Steroidal compounds for inhibiting steroid sulphatase |
| 04/24/2003 | WO2003033517A1 Ship 1 modulators |
| 04/24/2003 | WO2003033514A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 04/24/2003 | WO2003033511A1 Pt(iv) complex with antineoplastic activity: trans-[ptcl2(oh)2 (dimethylamine) (isopropylamine)] used as an antitumour agent |
| 04/24/2003 | WO2003033507A1 Benzylmalonic acid derivatives and proteasome inhibitors contaiing the same |
| 04/24/2003 | WO2003033506A1 Aminoborane acid derivative and proteasome inhibitory drug containing the same |
| 04/24/2003 | WO2003033502A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/24/2003 | WO2003033501A1 Himbacine analogues as thrombin receptor antagonists |
| 04/24/2003 | WO2003033499A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 04/24/2003 | WO2003033496A1 Beta-carbolin derivatives as ptp-inhibitors |
| 04/24/2003 | WO2003033494A1 Benzimidazole derivative |
| 04/24/2003 | WO2003033493A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ |
| 04/24/2003 | WO2003033491A1 Medicinal composition for prevention or alleviation of side effect of antitumor and medicinal antitumor composition |
| 04/24/2003 | WO2003033487A1 Piperidine- and piperazineacetamines as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 04/24/2003 | WO2003033484A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/24/2003 | WO2003033483A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 04/24/2003 | WO2003033482A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003033481A1 Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them |
| 04/24/2003 | WO2003033478A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors |
| 04/24/2003 | WO2003033472A1 Quinoline or quinazoline derivatives inhibiting auto- phosphorylation of fibroblast growth factor receptors |
| 04/24/2003 | WO2003033466A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 04/24/2003 | WO2003033457A1 Biphenyl-derivatives as p38-kinase inhibitors |
| 04/24/2003 | WO2003033456A1 NOVEL β-PHENYL-α-OXYSUBSTITUTED PROPIONIC DERIVATIVES: PROCESS FOR ITS PREPARATION AND THEIR USE IN THE PREPARATION OF PHARMACEUTICALLY IMPORTANT COMPOUNDS |
| 04/24/2003 | WO2003033455A1 Oligoamine compounds and derivatives thereof for cancer therapy |
| 04/24/2003 | WO2003033030A1 Pacap compositions and methods for tumor imaging and therapy |
| 04/24/2003 | WO2003033029A1 Replication competent dual-ad vectors for vaccine and immunotherapy applications |
| 04/24/2003 | WO2003033027A2 Dendrimers for use in targeted delivery |
| 04/24/2003 | WO2003033024A1 Cell proliferation inhibitor |
| 04/24/2003 | WO2003033021A1 Use of peptide vectors to improve the immune response to antigens |
| 04/24/2003 | WO2003033016A1 Use of neurotrophic factors for treating neurodegenerative diseases and cancer |
| 04/24/2003 | WO2003033013A1 Use of aplidine for the treatment of pancreatic cancer |
| 04/24/2003 | WO2003033012A1 Kahalalide compounds for use in cancer therapy |
| 04/24/2003 | WO2003033010A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 04/24/2003 | WO2003033006A1 Extract of ceratonia siliqua leaves and pods containing polyphenols with antioxidant and antitumor activities |
| 04/24/2003 | WO2003032999A1 Alkyne matrix metalloproteinase inhibitors |
| 04/24/2003 | WO2003032997A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 04/24/2003 | WO2003032993A1 Use of phosphorodiesterase iv inhibitors |
| 04/24/2003 | WO2003032988A1 Pharmaceutical composition |
| 04/24/2003 | WO2003032987A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032986A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032984A1 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 04/24/2003 | WO2003032982A1 Bis-heteroaryl alkanes as therapeutic agents |
| 04/24/2003 | WO2003032980A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032979A1 Malignant cell differentiation inducer compositions and utilization of the same |
| 04/24/2003 | WO2003032972A1 5’-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032964A2 Gap junctions and endothelial-derived hyperpolarizing factor (edhf) |
| 04/24/2003 | WO2003032955A1 Highly compressible ethylcellulose for tableting |
| 04/24/2003 | WO2003032950A1 Pharmaceutical formulation comprising (r) -bicalutamide |
| 04/24/2003 | WO2003032921A2 Treatment of neurodegenerative diseases and cancer of the brain |
| 04/24/2003 | WO2003032920A2 Oligonucleotide modulation of cell adhesion |
| 04/24/2003 | WO2003032916A2 Organosulfur inhibitors of tyrosine phosphatases |
| 04/24/2003 | WO2003032911A2 Anti-angiogenic and cytotoxic fused pyrimidines |
| 04/24/2003 | WO2003032910A2 Carbinols for the treatment of neuropathic dysfunction |
| 04/24/2003 | WO2003032907A2 High-concentration protein formulations and method of manufacture |
| 04/24/2003 | WO2003032906A2 Delivery of poorly soluble drugs |
| 04/24/2003 | WO2003032905A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
| 04/24/2003 | WO2003032903A2 Trisubstituted triazines compounds with antitubulin activity |
| 04/24/2003 | WO2003032902A2 Tumor targeted photodiagnostic-phototherapeutic agents |
| 04/24/2003 | WO2003032901A2 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 04/24/2003 | WO2003032900A2 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |